Characterization of community-acquired Staphylococcus aureus infections in children

Annals of Pharmacotherapy

Volumn 41, Issue 9, 2007, Pages 1361-1367

  Johnson, Peter N ^a,b   Rapp, Robert P ^c   Nelson, Christopher T ^d   Butler, J S ^e   Overman, Sue ^a,c   Kuhn, Robert J ^c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e University of Kentucky   (United States)

Author keywords

Kentucky; Methicillin resistant Staphylococcus aureus; Pediatrics

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CLINDAMYCIN; COTRIMOXAZOLE; LEVOFLOXACIN; PENICILLIN DERIVATIVE; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHILD; CONCURRENT VALIDITY; DEBRIDEMENT; DEMOGRAPHY; DIFFUSION; DRAIN; FEMALE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KENTUCKY; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34548148893     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K118     Document Type: Article

References (28)

1. Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 1982;97:330-8.
2. Saravolatz LD, Pohlod DJ, Arking LM. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982;97:325-9.
3. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 1999;282:1123-5.
4. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-8.
5. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785-91.
6. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community acquired methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J 2004;23:619-24.
7. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community acquired Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001;33:990-6.
8. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84.
9. Aguilar GM, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO, Kaplan SL. Community acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis 2004;23:701-6.
10. Sattler CA, Mason EO, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J 2002;21:910-6.
11. Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin (PVL) during a furunculosis outbreak in rural Alaska. J Infect Dis 2004;189:1565-73.
12. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005;115:642-8.
13. Gonzalez BE, Teruya J, Mahoney DH, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006;117:1673-9.
14. Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO, Kaplan SL. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin resistant Staphylococcus aureus infection. Clin Infect Dis 2006;43:953-60.
15. Gonzalez BE, Hulten KG, Dishop MK, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 2005;41:583-90.
16. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005;353:1245-51.
17. Aguilar GM, Hammerman WA, Mason EO, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003;22:593-8.
18. Fortunov RM, Hulten KG, Hammerman WA, Mason EO, Kaplan SL. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006;118:874-81.
19. Prevost G, Bouakham T, Piemont Y, et al. Characterization of a synergohymenotropic toxin produced by Staphylococcus intermedius. FEBS Lett 1995;376:135-40.
20. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in a rural American Indian community. JAMA 2001;286:1201-5.
21. Baggett HC, Hennessey TW, Leman R, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus infections in South-western Alaska. Infect Control Hosp Epidemiol 2003;24:397-402.
22. Centers for Disease Control and Prevention. Community-acquired methicillin-resistant Staphylococcus aureus. www.cdc.gov/ncidod/hip/ ARESIST/ca_mrsa_clinician.htm (accessed 2007 May 1).
23. Performance standards for antimicrobial disk susceptibility tests: approved standard. 9th ed. Wayne, PA: Clinical Laboratory Standards Institute, 2006.
24. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:5113-20.
25. Kaplan SL. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am 2005;19:747-57.
26. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123-7.
27. Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 2005;24:457-8.
28. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988:223,235,258.